Kennett Square, PA, United States
Boothwyn Pharmacy LLC recalls
1 recall recorded since 2018, most recently on 9 July 2025. 1 is listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)1
Terminated or completed0
Class I (FDA)0
Ongoing Class II, Class III Drugs
- Recall started
- 9 July 2025
- Reason
- Subpotent Drug
- Distribution
- U.S. Nationwide
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0608-2025, D-0607-2025, D-0606-2025, D-0609-2025
- Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
- Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496
- Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
- Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.